TETRAPHASE PHARMACEUTICALS INC Interest Paid, Excluding Capitalized Interest, Operating Activities
TETRAPHASE PHARMACEUTICALS INC reported Interest Paid, Excluding Capitalized Interest, Operating Activities of $1.96 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:InterestPaidNet · last filed 2020-05-07
- TETRAPHASE PHARMACEUTICALS INC interest paid, excluding capitalized interest, operating activities for the quarter ending 2019-12-31 was $0.00.
- TETRAPHASE PHARMACEUTICALS INC interest paid, excluding capitalized interest, operating activities for the quarter ending 2019-09-30 was $481.00K.
- TETRAPHASE PHARMACEUTICALS INC interest paid, excluding capitalized interest, operating activities for the quarter ending 2019-06-30 was $935.00K.
- TETRAPHASE PHARMACEUTICALS INC interest paid, excluding capitalized interest, operating activities for the quarter ending 2019-03-31 was $539.00K.
- TETRAPHASE PHARMACEUTICALS INC interest paid, excluding capitalized interest, operating activities for fiscal 2019 was $1.96M, a 307.29% increase from fiscal 2018.
- TETRAPHASE PHARMACEUTICALS INC interest paid, excluding capitalized interest, operating activities for fiscal 2018 was $480.00K.
| Period end | Interest Paid, Excluding Capitalized Interest, Operating Activities 3 month | Interest Paid, Excluding Capitalized Interest, Operating Activities 6 month | Interest Paid, Excluding Capitalized Interest, Operating Activities 9 month | Interest Paid, Excluding Capitalized Interest, Operating Activities 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $481.00K derived: sum of 2 quarters · filed 2020-03-12 | $1.42M derived: sum of 3 quarters · filed 2020-03-12 | $1.96M 10-K · filed 2020-03-12 |
| 2019-09-30 | $481.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $1.42M derived: sum of 2 quarters · filed 2019-11-12 | $1.96M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $935.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $1.47M 10-Q · filed 2019-08-08 | ||
| 2019-03-31 | $539.00K 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | $480.00K 10-K · filed 2020-03-12 |